You are here

Clinical Trials: Spinal Cord Injuries

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Thursday, September 23, 2021 - 12:00
Condition:   Spinal Cord Injury Cervical
Interventions:   Drug: WJ-MSC (XCEL-UMC-BETA);   Drug: Placebo
Sponsors:   Banc de Sang i Teixits;   Institut Guttmann;   Academic Research Organization (ARO) - VHIR
Not yet recruiting
Posted: Tuesday, August 24, 2021 - 12:00
Condition:   Spinal Cord Injuries
Intervention:   Biological: autologous adipose derived mesenchymal stem cells
Sponsor:   The Foundation for Orthopaedics and Regenerative Medicine
Posted: Tuesday, March 23, 2021 - 12:00
Conditions:   Spinal Cord Injury, Acute;   Spinal Cord Injury at C4 Level With Complete Lesion;   Spinal Cord Injury at C5-C7 Level With Complete Lesion
Intervention:   Biological: Neural precursor cells derived from human embryonic stem cell line
Sponsors:   S.Biomedics Co., Ltd.;   Linical Co., Ltd.;   Yonsei University
Not yet recruiting
Posted: Thursday, August 27, 2020 - 12:00
Condition:   Spinal Cord Injury
Interventions:   Biological: Autologous bone marrow-derived mononuclear cells;   Drug: Placebo
Sponsor:   Shanghai Changzheng Hospital
Not yet recruiting
Posted: Thursday, August 20, 2020 - 12:00
Conditions:   Spinal Cord Injuries;   Paralysis
Interventions:   Other: Best Medical Management: Occupational and Physical Therapy;   Biological: Autologous, Adipose Derived Mesenchymal Stem Cells
Sponsor:   Allan Dietz
Posted: Friday, February 28, 2020 - 12:00
Condition:   Spinal Cord Injuries
Interventions:   Biological: Collection and expansion of BM-MSC;   Diagnostic Test: VI-SCI evaluation and patients' follow up
Sponsor:   University of Jordan
Posted: Thursday, December 19, 2019 - 12:00
Condition:   Spinal Cord Injuries
Intervention:   Biological: Neuro-Cells
Sponsor:   Neuroplast
Not yet recruiting
Posted: Wednesday, October 23, 2019 - 12:00
Conditions:   Spinal Cord Injuries;   Tendinopathy;   Rotator Cuff Tears;   Shoulder Pain
Interventions:   Device: Lipogems;   Drug: Dexamethasone
Sponsor:   Kessler Foundation
Posted: Tuesday, August 13, 2019 - 12:00
Condition:   Acute Spinal Cord Injury
Interventions:   Drug: Normal Saline along with standard treatment;   Drug: PMZ-1620 along with standard treatment
Sponsor:   Pharmazz, Inc.
Posted: Friday, June 7, 2019 - 12:00
Condition:   Spinal Cord Injuries
Interventions:   Biological: Umbilical Cord Blood Mononuclear Cell;   Drug: Lithium Carbonate;   Other: Placebo;   Other: Locomotor Training
Sponsors:   StemCyte, Inc.;   Amarex Clinical Research
Not yet recruiting